| Erin Ashley Bolin, NP | |
|
207 Church St, Clover, SC 29710-1008 | |
| (803) 222-3063 | |
| Not Available |
| Full Name | Erin Ashley Bolin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 207 Church St, Clover, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407572134 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26665 (South Carolina) | Primary |
| Entity Name | Piedmont Physician Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194277186 PECOS PAC ID: 7911287552 Enrollment ID: O20161216001613 |
News Archive
Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Rush University Medical Center has received a three-year, $2.45 million grant from the U.S. Health Resources and Services Administration to support quality care for older Americans. Rush is one of only 44 health and education institutions in the country that the HRSA chose to become a Geriatrics Workforce Enhancement Program, which supports training and education that leads to better care for older adults.
Before people develop type 2 diabetes, they almost always have "prediabetes," defined as blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes. There are 79 million people in the United States who have prediabetes. Recent research has shown that even during prediabetes both heart and circulatory long-term damage to the body may already be occurring.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Ashley Bolin, NP 2782 Threefork Trail, Clover, SC 29710 Ph: (803) 579-1756 | Erin Ashley Bolin, NP 207 Church St, Clover, SC 29710-1008 Ph: (803) 222-3063 |
News Archive
Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Rush University Medical Center has received a three-year, $2.45 million grant from the U.S. Health Resources and Services Administration to support quality care for older Americans. Rush is one of only 44 health and education institutions in the country that the HRSA chose to become a Geriatrics Workforce Enhancement Program, which supports training and education that leads to better care for older adults.
Before people develop type 2 diabetes, they almost always have "prediabetes," defined as blood glucose levels that are higher than normal but not yet high enough to be diagnosed as diabetes. There are 79 million people in the United States who have prediabetes. Recent research has shown that even during prediabetes both heart and circulatory long-term damage to the body may already be occurring.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 1 days ago
Ms. Charlotte Anne Gott, F.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 980 Colleton Meadow Dr, Clover, SC 29710 Phone: 704-616-9747 | |
Mrs. Freedom Lee Proctor, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4724 Charlotte Hwy, Clover, SC 29710 Phone: 866-389-2727 | |
Sandra Defalco, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4724 Charlotte Hwy, Clover, SC 29710 Phone: 866-389-2727 | |
Tameika Hunter, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4724 Charlotte Hwy, Clover, SC 29710 Phone: 866-389-2727 | |
Mrs. Sara Marie Lightsey, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4724 Charlotte Hwy, Clover, SC 29710 Phone: 803-831-1911 | |
Virginie Padmore, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4724 Charlotte Hwy, Clover, SC 29710 Phone: 866-389-2727 |